BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20623948)

  • 1. [Disorders of bone mineral density in patients with cholelithiasis and postcholecystectomic syndrome].
    Koricheva ES; Il'chenko AA; Selezneva EIa; Drozdov VN
    Eksp Klin Gastroenterol; 2010; (4):14-20. PubMed ID: 20623948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV
    Faber J; Bech A; van Bentum P; Gisolf J; Hassing RJ; de Boer H
    AIDS Res Hum Retroviruses; 2020 Jan; 36(1):58-64. PubMed ID: 31523978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
    Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
    Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone mineral density disminution post Roux-Y bypass surgery].
    Papapietro K; Massardo T; Riffo A; Díaz E; Araya AV; Adjemian D; Montesinos G; Castro G
    Nutr Hosp; 2013; 28(3):631-6. PubMed ID: 23848081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone mineral density in patients with liver cirrhosis].
    Topcheeva ON; Drozdov VN; Embutnieks IuV; Viazhevich IuV
    Eksp Klin Gastroenterol; 2009; (8):51-5. PubMed ID: 20469679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
    Abeş M; Sarihan H; Madenci E
    J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents.
    Gupta G; Aronow WS
    J Am Med Dir Assoc; 2003; 4(4):200-2. PubMed ID: 12837141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guide to care for patients: Osteoporosis.
    Nurse Pract; 2009 Jun; 34(6):49-50. PubMed ID: 19474632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Digital computerized absorptiometry in the diagnosis of osteoporosis in a group of the severely mentally retarded].
    Múgica I; Ansa J; Sistiaga F; Zabalza R; Zubillaga P; Merino A; Mojedano B; Vidal C
    Nutr Hosp; 2002; 17(4):213-8. PubMed ID: 12395611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
    Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
    J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, prevention, and treatment of children with decreased bone mineral density.
    Szadek LL; Scharer K
    J Pediatr Nurs; 2014; 29(5):e3-14. PubMed ID: 24333239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of interleukin-1 and -6 in the etiopathogenesis of idiopathic osteoporosis and osteopenia in children.
    Rusińska A; Chlebna-Sokół D
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):257-65. PubMed ID: 15995586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of androgen deprivation therapy on bone mineral density in prostate cancer patients.
    Deng JH; Yang LP; Wang LS; Zhou DF
    Asian J Androl; 2004 Mar; 6(1):75-7. PubMed ID: 15064839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
    Wadhwa VK; Weston R; Mistry R; Parr NJ
    BJU Int; 2009 Sep; 104(6):800-5. PubMed ID: 19338564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density, osteopenia, and osteoporosis in the rhesus macaques of Cayo Santiago.
    Cerroni AM; Tomlinson GA; Turnquist JE; Grynpas MD
    Am J Phys Anthropol; 2000 Nov; 113(3):389-410. PubMed ID: 11042540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value and clinical indications of measurements of the bone mass using X-ray dual-photon absorptiometry].
    J Radiol; 1994; 75(8-9):441-55. PubMed ID: 7799288
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone mineral density and bone metabolic markers' status in children with neurofibromatosis type 1.
    Poyrazoğlu HG; Baş VN; Arslan A; Bastug F; Canpolat M; Per H; Gümüs H; Kumandas S
    J Pediatr Endocrinol Metab; 2017 Feb; 30(2):175-180. PubMed ID: 28125404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.